Division of Diabetes Endocrinology and Metabolism Archives
Powers announces plan to step down from key diabetes leadership roles
Oct. 17, 2023—Alvin C. Powers, MD, has announced plans to step down effective July 1, 2024, as director of the Vanderbilt Diabetes Center, director of the Vanderbilt Diabetes Research and Training Center, and chief of the Division of Diabetes, Endocrinology and Metabolism.
Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention
Oct. 17, 2023—A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes.
Takkouche named associate chief medical officer for Wilson and Sumner County regions
Sep. 12, 2023—Sahar Takkouche, MD, director of the Vanderbilt Weight Loss Center in Wilson County, has been named to the role of associate chief medical officer for Wilson and Sumner County regions.
Chase Hendrickson named executive medical director of the Medicine Patient Care Center
Jul. 26, 2023—Chase Hendrickson, MD, MPH, has been named executive medical director of the Medicine Patient Care Center.
Maternal diet influences postnatal diabetes risk
Jun. 13, 2023—Studies in a primate animal model suggest that islet hyperfunction — which in humans is associated with increased fat mass and Type 2 diabetes — is programmed in offspring by a maternal Western-style diet during pregnancy.
Saunders receives diabetes research innovation award
Mar. 23, 2023—Vanderbilt's Diane Saunders, PhD, has been selected as a 2023 recipient of an Innovation Award by the Network of Pancreatic Donors with Diabetes.
Diagnostic biomarker for bone disorder
Sep. 27, 2022—A urine chemical performs better as a diagnostic biomarker for the soft bone disease hypophosphatasia than other laboratory measures, Vanderbilt researchers have demonstrated.
Diabetes research grant receives NIDDK renewal
Sep. 8, 2022—The Vanderbilt Diabetes Research and Training Center is celebrating its 49th year of continual operation with the five-year competitive renewal of a $10.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health.
Diabetes, cardiovascular drug targets
May. 24, 2022—Targeting receptors of the inflammatory lipid signaling molecule PGE2 may offer a new way to tackle both Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.
Reducing obesity-related inflammation
Mar. 24, 2022—A treatment that increases levels of lipid signaling molecules reduced adipose tissue inflammation in obese adults, suggesting this pathway may be a valuable target for modulating fat and systemic inflammation.
VUMC mourns loss of dedicated clinician, teacher Fowler
Feb. 21, 2022—Vanderbilt's Michael Fowler, MD, associate professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, a celebrated Master Clinical Teacher, and co-medical director of the Shade Tree Clinic, died Feb. 20. He was 49.
International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes
Nov. 11, 2021— by Jill Clendening Nearly 400 investigators and scientific trainees hailing from 25 different countries recently gathered virtually, across continents and time zones, to share their latest research related to the immunology of Type 1 diabetes during the 18th Immunology of Diabetes Society (IDS) Congress, co-hosted by Vanderbilt University Medical Center and the University of...
